BH3-mimetic drugs: blazing the trail for new cancer medicines

D Merino, GL Kelly, G Lessene, AH Wei, AW Roberts… - Cancer cell, 2018 - cell.com
Defects in apoptotic cell death can promote cancer and impair responses of malignant cells
to anti-cancer therapy. Pro-survival BCL-2 proteins prevent apoptosis by keeping the cell …

Genetic control of programmed cell death during animal development

B Conradt - Annual review of genetics, 2009 - annualreviews.org
The elimination of unwanted cells by programmed cell death is a common feature of animal
development. Genetic studies in the nematode Caenorhabditis elegans, the fruit fly …

[HTML][HTML] Continuous T cell receptor signals maintain a functional regulatory T cell pool

JC Vahl, C Drees, K Heger, S Heink, JC Fischer… - Immunity, 2014 - cell.com
Regulatory T (Treg) cells maintain immune homeostasis and prevent inflammatory and
autoimmune responses. During development, thymocytes bearing a moderately self-reactive …

Bcl-2, Bcl-xL, and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells

D Mérino, SL Khaw, SP Glaser… - Blood, The Journal …, 2012 - ashpublications.org
Abstract The BH3-mimetic ABT-737 and an orally bioavailable compound of the same class,
navitoclax (ABT-263), have shown promising antitumor efficacy in preclinical and early …

Helios marks strongly autoreactive CD4+ T cells in two major waves of thymic deletion distinguished by induction of PD-1 or NF-κB

SR Daley, DY Hu, CC Goodnow - Journal of Experimental Medicine, 2013 - rupress.org
Acquisition of self-tolerance in the thymus requires T cells to discriminate strong versus
weak T cell receptor binding by self-peptide–MHC complexes. We find this discrimination is …

Macroautophagy substrates are loaded onto MHC class II of medullary thymic epithelial cells for central tolerance

M Aichinger, C Wu, J Nedjic, L Klein - Journal of Experimental Medicine, 2013 - rupress.org
Macroautophagy serves cellular housekeeping and metabolic functions through delivery of
cytoplasmic constituents for lysosomal degradation. In addition, it may mediate the …

[HTML][HTML] Combined venetoclax and alvocidib in acute myeloid leukemia

J Bogenberger, C Whatcott, N Hansen, D Delman… - Oncotarget, 2017 - ncbi.nlm.nih.gov
More effective treatment options for elderly acute myeloid leukemia (AML) patients are
needed as only 25–50% of patients respond to standard-of-care therapies, response …

Bcl-2 allows effector and memory CD8+ T cells to tolerate higher expression of Bim

S Kurtulus, P Tripathi… - The Journal of …, 2011 - journals.aai.org
As acute infections resolve, most effector CD8+ T cells die, whereas some persist and
become memory T cells. Recent work showed that subsets of effector CD8+ T cells …

Bcl-2-regulated cell death signalling in the prevention of autoimmunity

D Tischner, C Woess, E Ottina, A Villunger - Cell death & disease, 2010 - nature.com
Cell death mediated through the intrinsic, Bcl-2-regulated mitochondrial apoptosis signalling
pathway is critical for lymphocyte development and the establishment of central and …

miR‐148a is upregulated by Twist1 and T‐bet and promotes Th1‐cell survival by regulating the proapoptotic gene Bim

C Haftmann, AB Stittrich, J Zimmermann… - European journal of …, 2015 - Wiley Online Library
Repeatedly activated T helper 1 (Th1) cells present during chronic inflammation can
efficiently adapt to the inflammatory milieu, for example, by expressing the transcription …